News - Inspiration Biopharmaceuticals, Pharmaceutical


Popular Filters

Ipsen and Inspiration Biopharma in deal with Baxter for OBI-1


French drugmaker Ipsen (Euronext: IPN) and privately-held US firm Inspiration Biopharmaceuticals have…

Baxter InternationalIB1001Inspiration BiopharmaceuticalsIpsenMergers & AcquisitionsOBI-1Pharmaceutical

Regulatory briefs from Ipsen/Inspiration, Janssen and Astellas


French drugmaker Ipsen (Euronext: IPN) and partner USA-based privately-held Inspiration Biopharmaceuticals…

Astellas PharmaBiotechnologyEuropeInspiration BiopharmaceuticalsIpsenJanssen-CilagJohnson & JohnsonNorth AmericaOBI-1OncologyPharmaceuticalRegulationTarcevaZytiga

Ipsen's hemophilia partner Inspiration Biopharma seeks Chapter 11 protection


French drugmaker Ipsen (Euronext: IPN) announced yesterday that its partner, privately-held US firm Inspiration…

FinancialInspiration BiopharmaceuticalsIpsenPharmaceutical

Ipsen and Inspiration renegotiate hemophilia agreement


French drugmaker Ipsen (Euronext: IPN) said yesterday that it has renegotiated its 2010 strategic partnership…

FinancialIB1001Inspiration BiopharmaceuticalsIpsenLicensingOBI-1Pharmaceutical

US FDA puts clinical hold on Ipsen and Inspiration's hemophilia drug candidate


There was bad news for French drugmaker Ipsen (Euronext: IPN) and partner privately-held US firm Inspiration…

IB1001Inspiration BiopharmaceuticalsIpsenNorth AmericaPharmaceuticalRegulationResearch

ThromboGenics re-files ocriplasmin BLA and Inspiration submits IB 1001 to FDA


Belgian biopharma company ThromboGenics NV (Euronext Brussels: THR) said this morning that it has resubmitted…

BiotechnologyInspiration BiopharmaceuticalsIpsenNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenics

Inspiration gets $25 million milestone from hemophilia collaboration partner Ipsen


Privately-held US firm Inspiration Biopharmaceuticals says it has initiated patient enrollment in the…

Inspiration BiopharmaceuticalsIpsenLicensingPharmaceuticalResearch

Inspiration Biopharma earns $35 million milestone from Ipsen on acceptance of hemophilia drug MAA


French drugmaker Ipsen (Euronext: IPN) and its partner, privately-held Inspiration Biopharmaceuticals…

Cardio-vascularEuropeInspiration BiopharmaceuticalsIpsenLicensingPharmaceuticalRegulation

Ipsen leaps on strong first-half results; expands links with Inspiration Biopharma and names new CFO


On a very busy news days for French drugmaker Ipsen (Euronext: IPN), the company saw its shares jump…

FinancialInspiration BiopharmaceuticalsIpsenLicensingManagementPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top